CureMatch
×
  • Patients
  • Physicians
  • About Us
  • News
    • CureMatch News
    • Validation and Research
    • Events and Conferences
  • Contact
  • en

CureMatch Wins MetroConnect PitchFest $35,000 Grand Prize

CureMatch Wins MetroConnect PitchFest $35,000 Grand Prize
June 8, 2018Awards

SAN DIEGO – June 8, 2018, World Trade Center San Diego and a live voting audience awarded $35K to local digital health oncology company CureMatch, as part of the MetroConnect Grand Prize PitchFest. Thank you to World Trade Center San Diego, and the grant awarded by JPMorgan Chase & Co. The real winners are those around the world benefiting from CureMatch’s continued innovation and technology in Precision Medicine developed specifically to help oncology professionals find the best cancer treatments.

►15 Million new cancer diagnosis each year GLOBALLY

►80% of them are getting the WRONG TREATMENT

►CureMatch finds ranks and matches FDA-approved CANCER TREATMENTS based on the DNA of a patient’s cancer


World Trade Center San Diego, through a grant provided by JPMorgan Chase & Co., and more than 100 business and community leaders awarded the MetroConnect Grand Prize to CureMatch, Inc, a local digital health company focused on personalized medicine and oncology.

“Three years in, the success of the MetroConnect program points to the importance of global trade and connectivity,” said Nikia Clarke, Ph.D., executive director of World Trade Center San Diego, the organization administering the grants. “From securing distribution partnerships in Japan to inking deals in key biotech hubs across the EU, the MetroConnect Grand Prize finalists are sharing their life-changing innovation with the world, helping strengthen San Diego’s economy and workforce.”

Managed by World Trade Center San Diego, an affiliate of the San Diego Regional EDC, and presented by JPMorgan Chase, the MetroConnect Grand Prize offers $35,000 to one of 15 companies to aid in their foreign market expansion. The finalists competing were CureMatch, FoxFury, Planck Aerosystems and Tioga Research.

The benefits of companies going global and engaging foreign markets are well-documented. According to the Brookings Institution, companies that are global pay their employees higher wages, are less likely to go out of business and spur more efficient development of technology and R&D.

In 2017 alone, San Diego exported $23.8 billion in goods and services from diverse industries including aircraft manufacturing to pharmaceutical R&D. Small- to medium-sized businesses produce 92 percent of those goods – undergirding the importance of programs like MetroConnect.

Now in its third year, MetroConnect has emerged as the region’s premier export assistance program. Run by World Trade Center San Diego, 15 companies are selected on an annual basis and equipped with a suite of programmatic and financial resources to help them in their plans to go global. Out of 50 applicants in 2017, just 15 San Diego companies were awarded the initial $10,000 MetroConnect grant, funded by JPMorgan Chase. Since the program’s inception in 2015, the cohort companies have produced an additional $15 million in export sales and 161 new jobs for the region, collectively.

A panel of judges consisting of business and community leaders reviewed the companies’ respective accomplishments and goals as a means of selecting the top four finalists to present at the Grand Prize event: CureMatch, FoxFury, Planck Aerosystems and Tioga Research.

“CureMatch is thrilled to win the Pitchfest, with special thanks to World Trade Center San Diego and JPMorgan Chase,” said Stephane Richard, Ph.D., president and CEO of CureMatch.

“Cancer has no boundaries, so while CureMatch was born in San Diego, we believe that every one of the more than 15 million people diagnosed with cancer this year deserves the best treatment. This grand prize will help CureMatch save more lives around the world.”

“JPMorgan Chase is committed to helping local businesses connect to the global marketplace,” said Tim West, region manager of JPMorgan Chase’s Middle Market Commercial Banking practice in San Diego. “We congratulate the finalists for their efforts to grow their businesses internationally while creating jobs and boosting our local economy.”

For more information about MetroConnect, visit MetroConnectsd.org.

About World Trade Center San Diego
World Trade Center San Diego operates as an affiliate of San Diego Regional Economic Development Corporation. WTC San Diego works to further San Diego’s global competitiveness by building an export pipeline, attracting and retaining foreign investment and increasing San Diego’s global profile abroad. sandiegobusiness.org/wtcsd

About CureMatch®
CureMatch, Inc. is a digital precision oncology company bridging the gap between legacy cancer treatments and advances in personalized medicine. CureMatch scores and ranks Personalized Combination Therapy® options to target specific molecular aberrations in cost-effective PreciGENE reports. This actionable intelligence guides oncologists to effectively customize treatment for each individual patient. Based in San Diego, CA, the CureMatch technology has expert foundation in supercomputing, oncology, genetics, proteomics, biochemistry, and cell biology. For more information, visit www.curematch.com

CureMatch Media Contact:
Name: Larissa Anderson
Company: CureMatch
Phone: (858) 859-2873
Email: press@curematch.com

Share

  • LinkedIn
  • Facebook
  • Twitter
  • Reddit
  • Email
  • Print

Add Comment Cancel


Receive CureMatch News

Sign up for free personalized oncology information and resources.
* = required field

Recent News & Resources

  • J&J Innovation Podcast Features CureMatch’s Stephane Richard Sep 10

    Tune in to the J&J Innovation Podcast series featuring CureMatch’s Stephane Richard. J&J’s host, Caroline...

  • Kolmogorov Complexity Methodologies Helps Fight Cancer Aug 21

    CureMatch shares theories of 'Kolmogorov Complexity' to optimize descriptor selection at AIMed Summit. Just as...

  • CureMatch Recognized as Best Artificial Intelligence (AI) Company in Healthcare Jul 12

    Recognized as the “Best AI-based Solution for Healthcare” by AI Breakthrough, an independent organization that...

  • CureMatch Precision Medicine Leaders Featured at Summit: Stephane Richard and Jessica Federer at PMLS2018 Jun 26

    Jessica Federer Joins Advisory Board to Advance Cancer Cures. Stephane Richard and Jessica Federer to speak...

  • CureMatch at WIN Symposium 2018 Winning the War against Cancer with Precision Oncology Jun 22

    SAN DIEGO, CA – June 22, 2018 – CureMatch, Inc. offers results of an artificial...

  • CureMatch Awarded by JPMorgan Chase and World Trade Center San Diego for Global Market Expansion Jun 14

    SAN DIEGO, CA – June 14, 2018: CureMatch wins Metroconnect startup pitchfest. Global expansion to...

  • CureMatch Wins MetroConnect PitchFest $35,000 Grand Prize Jun 8

    SAN DIEGO – June 8, 2018, World Trade Center San Diego and a live voting audience...

Validation

  • CureMatch at WIN Symposium 2018 Winning the War against Cancer with Precision Oncology Jun 22

    SAN DIEGO, CA – June 22, 2018 – CureMatch, Inc. offers results...

  • Personalized Drug Combinations Can Lead to Better Results for Cancer Patients Apr 16

    A featured article in The Scientist magazine highlights CureMatch co-founder Dr. Razelle...

  • CureMatch Presents PreciGENE Performance Results at AACR Annual Meeting Apr 13

    Exciting results obtained by our decision-support platform - we presented our research...

  • Personalized Drug Combinations More Effective than Current Standard of Care for Pancreatic Cancer Apr 12

    New study published in ANTICANCER RESEARCH Journal offers potential proof-of-concept for precision...

Archives

  • September 2018 (1)
  • August 2018 (1)
  • July 2018 (1)
  • June 2018 (5)
  • May 2018 (1)
  • April 2018 (4)
  • March 2018 (1)
  • February 2018 (3)
  • January 2018 (4)
  • December 2017 (3)
  • November 2017 (1)
  • October 2017 (1)
  • September 2017 (3)
  • August 2017 (4)
  • June 2017 (6)
  • May 2017 (9)
  • April 2017 (11)
  • March 2017 (8)
  • February 2017 (3)
  • January 2017 (5)
  • October 2016 (1)
  • September 2016 (5)
  • August 2016 (2)
  • May 2016 (1)
  • April 2016 (1)

logo

+1 (858) 859-2873

FAX: +1 (858) 430-5813

Quick Links

  • Patients
  • Physicians
  • About CureMatch
  • News and Latest Posts
    • CureMatch News
    • Validation and Case Studies
    • Events and Conferences
    • Videos
  • Contact Us
  • FAQ

Latest News and Results

  • J&J Innovation Podcast Features CureMatch’s Stephane Richard Sep 10

    Tune in to the J&J Innovation Podcast series featuring CureMatch’s Stephane Richard. J&J’s host, Caroline...

  • Kolmogorov Complexity Methodologies Helps Fight Cancer Aug 21

    CureMatch shares theories of 'Kolmogorov Complexity' to optimize descriptor selection at AIMed Summit. Just as...

  • CureMatch Recognized as Best Artificial Intelligence (AI) Company in Healthcare Jul 12

    Recognized as the “Best AI-based Solution for Healthcare” by AI Breakthrough, an independent organization that...

© 2019 CureMatch, Inc. CureMatch is a registered trademark.
FAQ | Terms of Use | Privacy Policy | HIPAA Notice

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data

We’d like to send you a CureMatch PreciGENE® Sample Analysis

 

Sample CureMatch Report Download

  • This field is for validation purposes and should be left unchanged.

 

We value and respect your privacy and will not publish, share, or sell your contact information.

View Privacy Policy